The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $74.85

Today's change-1.47 -1.93%
Updated January 24 4:01 PM EST. Delayed by at least 15 minutes.
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $74.85

Today's change-1.47 -1.93%
Updated January 24 4:01 PM EST. Delayed by at least 15 minutes.

Eli Lilly and Co crosses below 20-day moving average

Eli Lilly and Co closed sharply lower Tuesday, dropping (U.S.)$1.47 or 1.93% to (U.S.)$74.85 and crossing below its 20-day moving average. Over the last five days, shares have lost 2.60% and 9.25% over the last 52 weeks. This security has underperformed the S&P 500 by 28.82% during the last year.

Key company metrics

  • Open(U.S.) $76.20
  • Previous close(U.S.) $76.32
  • High(U.S.) $76.43
  • Low(U.S.) $74.17
  • Bid / Ask(U.S.) $74.41 / (U.S.) $75.00
  • YTD % change+1.77%
  • Volume6,586,960
  • Average volume (10-day)5,410,821
  • Average volume (1-month)5,380,659
  • Average volume (3-month)5,460,135
  • 52-week range(U.S.) $64.18 to (U.S.) $83.79
  • Beta0.30
  • Trailing P/E32.51×
  • P/E 1 year forward21.53×
  • Forward PEG2.07×
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield2.78%
  • Trailing EPS(U.S.) $2.30
Updated January 24 4:01 PM EST. Delayed by at least 15 minutes.
S&P TSX0.84%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue5,1925,4054,8655,376
Total other revenue--------
Total revenue5,1925,4054,8655,376
Gross profit3,7913,9403,5423,986
Total cost of revenue1,4011,4651,3231,389
Total operating expense4,2484,4824,1494,976
Selling / general / administrative1,5651,6231,4741,798
Research & development1,2361,3361,2211,444
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)4658131344
Other operating expenses, total--------
Operating income944923716400
Interest income (expense), net non-operating-58-57-57-57
Gain (loss) on sale of assets--------
Other--------
Income before tax971945567445
Income after tax778748440478
Income tax, total193197127-34
Net income778748440478
Total adjustments to net income--------
Net income before extra. items778748440478
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items778748440478
Inc. avail. to common incl. extra. items778748440478
Diluted net income778748440478
Dilution adjustment--------
Diluted weighted average shares1,0611,0601,0631,063
Diluted EPS excluding extraordinary itemsvalue per share0.730.710.410.45
Dividends per sharevalue per share0.510.510.510.60
Diluted normalized EPSvalue per share0.770.750.510.73